Northern Oak Wealth Management Inc. raised its position in shares of CVS Health Corporation (NYSE:CVS) by 68.9% during the first quarter, according to its most recent disclosure with the SEC. The firm owned 57,406 shares of the pharmacy operator’s stock after buying an additional 23,413 shares during the period. Northern Oak Wealth Management Inc.’s holdings in CVS Health Corporation were worth $4,506,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in CVS. Financial Advisors Network Inc. boosted its position in shares of CVS Health Corporation by 7.4% in the first quarter. Financial Advisors Network Inc. now owns 7,380 shares of the pharmacy operator’s stock worth $593,000 after buying an additional 508 shares in the last quarter. Brighton Jones LLC acquired a new position in shares of CVS Health Corporation during the first quarter worth about $753,000. First City Capital Management Inc. boosted its position in shares of CVS Health Corporation by 0.3% in the first quarter. First City Capital Management Inc. now owns 12,771 shares of the pharmacy operator’s stock worth $1,003,000 after buying an additional 40 shares in the last quarter. Gardiner Nancy B boosted its position in shares of CVS Health Corporation by 2.8% in the first quarter. Gardiner Nancy B now owns 18,954 shares of the pharmacy operator’s stock worth $1,489,000 after buying an additional 509 shares in the last quarter. Finally, Security National Bank of SO Dak boosted its position in shares of CVS Health Corporation by 31.4% in the first quarter. Security National Bank of SO Dak now owns 12,504 shares of the pharmacy operator’s stock worth $981,000 after buying an additional 2,988 shares in the last quarter. Institutional investors own 82.31% of the company’s stock.

CVS Health Corporation (NYSE CVS) traded up 0.53% during midday trading on Monday, reaching $79.83. 731,391 shares of the company’s stock traded hands. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $98.44. The stock has a 50-day moving average of $78.83 and a 200 day moving average of $78.96. The company has a market cap of $81.15 billion, a P/E ratio of 15.90 and a beta of 0.91.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings data on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The company had revenue of $45.69 billion during the quarter, compared to the consensus estimate of $45.36 billion. During the same quarter in the prior year, the firm posted $1.32 earnings per share. The firm’s revenue was up 4.5% compared to the same quarter last year. On average, analysts anticipate that CVS Health Corporation will post $5.88 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 3rd. Stockholders of record on Monday, July 24th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.52%. The ex-dividend date was Thursday, July 20th. CVS Health Corporation’s dividend payout ratio is currently 39.92%.

COPYRIGHT VIOLATION NOTICE: This article was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://www.watchlistnews.com/northern-oak-wealth-management-inc-acquires-23413-shares-of-cvs-health-corporation-cvs/1487277.html.

A number of brokerages have recently issued reports on CVS. Wolfe Research restated a “peer perform” rating on shares of CVS Health Corporation in a research note on Monday. BidaskClub upgraded shares of CVS Health Corporation from a “sell” rating to a “hold” rating in a research note on Wednesday, August 2nd. Jefferies Group LLC restated a “hold” rating and issued a $82.00 price objective on shares of CVS Health Corporation in a research note on Friday, July 14th. Guggenheim restated a “buy” rating on shares of CVS Health Corporation in a research note on Monday, July 3rd. Finally, Needham & Company LLC began coverage on shares of CVS Health Corporation in a research note on Tuesday, June 27th. They issued a “hold” rating for the company. Eight equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $91.27.

In other news, EVP Helena Foulkes sold 20,332 shares of the company’s stock in a transaction that occurred on Monday, June 19th. The stock was sold at an average price of $76.98, for a total value of $1,565,157.36. Following the completion of the transaction, the executive vice president now owns 59,300 shares of the company’s stock, valued at $4,564,914. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO David M. Denton sold 230,510 shares of the company’s stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $80.00, for a total value of $18,440,800.00. Following the completion of the transaction, the chief financial officer now directly owns 176,983 shares of the company’s stock, valued at approximately $14,158,640. The disclosure for this sale can be found here. Insiders sold 271,175 shares of company stock valued at $21,632,597 in the last ninety days. 0.61% of the stock is currently owned by insiders.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.